Authors:
DUCREUX M
ROUGIER P
FANDI A
CLAVEROFABRI MC
VILLING AL
FASSONE F
FANDI L
ZARBA J
ARMAND JP
Citation: M. Ducreux et al., EFFECTIVE TREATMENT OF ADVANCED BILIARY-TRACT CARCINOMA USING 5-FLUOROURACIL CONTINUOUS-INFUSION WITH CISPLATIN, Annals of oncology, 9(6), 1998, pp. 653-656
Authors:
MITRY E
BAUDIN E
DUCREUX M
SABOURIN JC
YAKENDJI K
RUFFIE P
LASSER P
SCHLUMBERGER M
ROUGIER P
Citation: E. Mitry et al., TREATMENT OF POORLY DIFFERENTIATED NEUROENDOCRINE TUMORS (PDNET) WITHETOPOSIDE (VP16) AND CISPLATIN (CDDP), Annals of oncology, 9, 1998, pp. 226-226
Authors:
SEITZ JF
DUCREUX M
YCHOU M
BONNAY M
ROUGIER P
MIGNARD D
ARMAND JP
Citation: Jf. Seitz et al., PHASE I II STUDY OF CPT-II IN COMBINATION WITH LV5FU2 (DE GRAMONT-REGIMEN) EVERY 2 WEEKS FOR THE TREATMENT OF COLORECTAL-CANCER (CRC) AFTER5-FU FAILURE/, Annals of oncology, 9, 1998, pp. 261-261
Authors:
BECOUARN Y
YCHOU M
DUCREUX M
BOREL C
BERTHEAULTCVITKOVIC F
SEITZ JF
NASCA S
NGUYEN TD
PAILLOT B
RAOUL JL
DUFFOUR J
FANDI A
DUPONTANDRE G
ROUGIER P
Citation: Y. Becouarn et al., PHASE-II TRIAL OF OXALIPLATIN AS FIRST-LINE CHEMOTHERAPY IN METASTATIC COLORECTAL-CANCER PATIENTS, Journal of clinical oncology, 16(8), 1998, pp. 2739-2744
Authors:
GRIMALDI C
BLEIBERG H
GAY F
MESSNER M
ROUGIER P
KOK TC
CIRERA L
CERVANTES A
DEGREVE J
PAILLOT B
BUSET M
NITTI D
SAHMOUD T
DUEZ N
WILS J
Citation: C. Grimaldi et al., EVALUATION OF ANTIANDROGEN THERAPY IN UNRESECTABLE HEPATOCELLULAR-CARCINOMA - RESULTS OF A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENTOF CANCER MULTICENTRIC DOUBLE-BLIND TRIAL, Journal of clinical oncology, 16(2), 1998, pp. 411-417
Authors:
LEVY E
PIEDBOIS P
BUYSE M
PIGNON JP
ROUGIER P
RYAN L
HANSEN R
ZEE B
WEINERMAN B
PATER J
LEICHMAN C
MACDONALD J
BENEDETTI J
LOKICH J
FRYER J
BRUFMAN G
ISACSON R
LAPLANCHE A
QUINAUX E
THIRION P
RYAN L
HANSEN R
HARRINGTON D
MCFADDEN E
RIBBLE A
JACOBSON R
ZEE B
WEINERMAN B
PATER J
LEICHMAN C
MACDONALD J
BENEDETTI J
LOKICH J
FRYER J
PIGNON JP
LAPLANCHE A
LUBOINSKI M
ROUGIER P
BRUFMAN G
ISACSON R
VAITKEVICIUS V
PIEDBOIS P
LEBOURGEOIS JP
PIEDBOIS Y
GAUTHIER E
LEVY E
THIRION P
DURANDZALENSKI I
BUYSE M
QUINAUX E
WOLMARK N
PIEDBOIS P
BUYSE M
CARLSON R
RUSTUM Y
ERLICHMAN C
Citation: E. Levy et al., TOXICITY OF FLUOROURACIL IN PATIENTS WITH ADVANCED COLORECTAL-CANCER - EFFECT OF ADMINISTRATION SCHEDULE AND PROGNOSTIC FACTORS, Journal of clinical oncology, 16(11), 1998, pp. 3537-3541
Authors:
BLEIBERG H
SAHMOUD T
DILEO A
CUNNINGHAM D
ROUGIER P
Citation: H. Bleiberg et al., ADEQUATE NUMBER OF PATIENTS ARE NEEDED TO EVALUATE ADJUVANT TREATMENTIN GASTRIC-CANCER, Journal of clinical oncology, 16(11), 1998, pp. 3714-3714
Authors:
WOLMARK N
PIEDBOIS P
ROUGIER P
BUYSE M
PIGNON JP
RYAN L
HANSEN R
ZEE B
WEINERMAN B
PATER J
LEICHMAN C
MACDONALD J
BENEDETTI J
LOKICH J
FRYER J
BRUFMAN G
ISACSON R
LAPLANCHE A
LEVY E
HARRINGTON D
MCFADDEN E
RIBBLE A
JACOBSON R
LUBOINSKI M
VAITKEVICIUS V
LEBOURGEOIS JP
PIEDBOIS Y
GAUTHIER E
DURANDZALESKI I
CARLSON R
RUSTUM Y
ERLICHMAN C
Citation: N. Wolmark et al., EFFICACY OF INTRAVENOUS CONTINUOUS-INFUSION OF FLUOROURACIL COMPARED WITH BOLUS ADMINISTRATION IN ADVANCED COLORECTAL-CANCER, Journal of clinical oncology, 16(1), 1998, pp. 301-308
Citation: P. Rougier et Jf. Seitz, WHICH ADJUVANT TREATMENTS AND WHAT ARE TH EIR INDICATIONS FOLLOWING RESECTION FOR CURE IN COLONIC-CANCER, Gastroenterologie clinique et biologique, 22(3BIS), 1998, pp. 131-146
Authors:
BAKER J
BLEIBERG H
HUTCHISON G
JACKMAN A
KERR D
LABIANCA R
MACDONALD J
MEYER HJ
MINSKY B
NORDLINGER B
ROUGIER P
SMITS S
SOBRERO A
TAYLOR I
VERWEIJ J
Citation: J. Baker et al., AN INTERNATIONAL MULTIDISCIPLINARY APPROACH TO THE MANAGEMENT OF ADVANCED COLORECTAL-CANCER (FIRST OF 2 PARTS) (REPRINTED FROM EUR-J-SURG-ONCOL, VOL 23, SUPPL A, AUGUST 1997), Annales chirurgiae et gynaecologiae, 87(3), 1998, pp. 255-264
Authors:
WILS J
SAHMOUD T
SOBRERO A
BLEIBERG H
AHMEDZAI S
BLAZEBY J
BLIJHAM G
CONROY T
CUNNINGHAM D
CURRAN D
DIAZRUBIO E
DUCREUX M
EVANS J
GLIMELIUS B
HUTCHINSON G
KERR D
KIEBERT G
KOHNE H
LABIANCA R
LANGENDIJK R
NITTI D
NORDLINGER B
ROUGIER P
SCHEITHAUER W
SCHMOLL HJ
VANCUTSEM E
WAGENER T
WILKE J
MARINUS A
THERASSE P
Citation: J. Wils et al., EVALUATION OF CLINICAL EFFICACY OF NEW MEDICAL TREATMENTS IN ADVANCEDCOLORECTAL-CANCER - RESULTS OF A WORKSHOP ORGANIZED BY THE EORTC GITCCG, Tumori, 84(3), 1998, pp. 335-347
Authors:
FARRES MT
DEBAERE T
LAGRANGE C
RAMIREZ L
ROUGIER P
MUNCK JN
ROCHE A
Citation: Mt. Farres et al., PERCUTANEOUS MITOXANTRONE INJECTION FOR PRIMARY AND SECONDARY LIVER-TUMORS - PRELIMINARY-RESULTS, Cardiovascular and interventional radiology, 21(5), 1998, pp. 399-403
Authors:
PELLETIER G
DUCREUX M
GAY F
LUBOINSKI M
HAGEGE H
DAO T
VANSTEENBERGEN W
BUFFET C
ROUGIER P
ADLER M
PIGNON JP
ROCHE A
Citation: G. Pelletier et al., TREATMENT OF UNRESECTABLE HEPATOCELLULAR-CARCINOMA WITH LIPIODOL CHEMOEMBOLIZATION - A MULTICENTER RANDOMIZED TRIAL, Journal of hepatology, 29(1), 1998, pp. 129-134
Citation: P. Rougier, RANDOMIZED TRIAL OF IRINOTECAN FLUOROURACIL BY CONTINUOUS-INFUSION FLUOROURACIL FAILURE IN PATIENTS WITH METASTATIC COLORECTAL-CANCER (VOL 352, PG 1407, 1998), Lancet, 352(9140), 1998, pp. 1634-1634
Authors:
ROUGIER P
VANCUTSEM E
BAJETTA E
NIEDERLE N
POSSINGER K
LABIANCA R
NAVARRO M
MORANT R
BLEIBERG H
WILS J
AWAD L
HERAIT P
JACQUES C
Citation: P. Rougier et al., RANDOMIZED TRIAL OF IRINOTECAN VERSUS FLUOROURACIL BY CONTINUOUS-INFUSION AFTER FLUOROURACIL FAILURE IN PATIENTS WITH METASTATIC COLORECTAL-CANCER, Lancet, 352(9138), 1998, pp. 1407-1412
Authors:
ROUGIER P
SAHMOUD T
NITTI D
CURRAN D
DOCI R
DEWAELE B
NAKAJIMA T
RAUSCHECKER H
LABIANCA R
PECTOR JC
MARSONI S
APOLONE G
LASSER P
COUVREUR ML
WILS J
Citation: P. Rougier et al., ADJUVANT PORTAL-VEIN INFUSION OF FLUOROURACIL AND HEPARIN IN COLORECTAL-CANCER - A RANDOMIZED TRIAL, Lancet, 351(9117), 1998, pp. 1677-1681
Citation: Y. Becouarn et P. Rougier, CLINICAL EFFICACY OF OXALIPLATIN MONOTHERAPY - PHASE-II TRIALS IN ADVANCED COLORECTAL-CANCER, Seminars in oncology, 25(2), 1998, pp. 23-31
Citation: E. Mitry et P. Rougier, ROLE OF ADJUVANT CHEMOTHERAPY IN THE MANAGEMENT OF CANCER OF THE RECTUM, La Semaine des hopitaux de Paris, 74(27-28), 1998, pp. 1052-1057
Authors:
FAIVRE J
ADENIS A
BRETAGNE JF
CARPENTIER F
DUROCHER A
DEBECO I
FOURNET J
GIGNOUX M
GUYOT P
LEGOUX JL
MEYER C
PAPAZIAN A
PIENKOWSKI P
POTET F
SANCHOGARNIER H
SEITZ JF
ARNAUD JP
AUDIGIER JC
CASSIGNEUL J
CONROY T
DESAINTLOUVENT P
ESTEVE J
LHERMINE C
LASSER P
MAGNIER AM
MANDARD AM
MANTZ JM
PILLON D
ROY P
RUSZNIEWSKI M
SALLE E
SOUWEINE G
ARVEUX P
BEDENNE L
BENAMOUZIG R
BENHAMICHE AM
BERARD P
BOUTRONRUAULT MC
BOYER J
CANARD JM
DELPERO JR
DIEBOLD MD
DORVAL ED
DUCREUX M
GROSCLAUDE P
JAECK D
KRONBORG O
LAUNOY G
LEFEBVRE R
LEHUR PA
MAUREL J
MONGES G
MONNET E
OLSCHWANG S
PIARD F
ROUGIER P
SCHAFFER P
TIRET E
THOUVENIN D
BARRAT C
HERBERT C
LOUVET C
PENNA C
POL B
SIPROUDHIS L
Citation: J. Faivre et al., PREVENTION, SCREENING AND MANAGEMENT OF C OLON-CANCER, La Semaine des hopitaux de Paris, 74(15-16), 1998, pp. 709-717
Authors:
APARICIO T
DUCREUX M
MITRY E
BAUDIN E
SABOURIN JC
SCHLUMBERGER M
ROUGIER P
Citation: T. Aparicio et al., ANTITUMORAL ACTIVITY OF SOMATOSTATIN ANALOGS (SA) IN 34 METASTATIC AND PROGRESSIVE ENDOCRINE GASTROENTEROPANCREATIC (GEP) TUMORS, Gastroenterology, 114(4), 1998, pp. 2283-2283
Authors:
JAIS P
SABOURIN JC
BOMBLED J
ROUGIER P
LASSER P
DUVILLARD P
BENARD J
BRESSACDEPAILLERETS B
Citation: P. Jais et al., ABSENCE OF SOMATIC ALTERATIONS OF THE EB1 GENE APC-ASSOCIATED PROTEININ HUMAN SPORADIC COLORECTAL-CANCER, Gastroenterology, 114(4), 1998, pp. 2531-2531
Authors:
CONROY T
ADENIS A
LASSER P
MERROUCHE Y
MONGES G
RIVOIRE M
ROUGIER P
RUGGIERIPIGNON S
SARRADET A
TOMA C
Citation: T. Conroy et al., STANDARDS, OPTIONS AND RECOMMENDATIONS FOR THE FOLLOW-UP AFTER TREATMENT FOR COLONIC-CANCER, Bulletin du cancer, 85(2), 1998, pp. 152-159